Intense thinking for API manufacture

How to drive process intensification, continuous manufacturing, and biocatalysis into API processes. Delivering improved control, efficiency and compliance whilst reducing the carbon footprint of medicines manufacture whilst enhancing national security and resilience.


CLIVE BADMAN OBE | Executive Director | University of Strathclyde


MARK TALFORD | Deputy Challenge Director | Medicines Manufacturing
SALVATORE MASCIA | Founder & Chief Executive Officer | CONTINUUS Pharmaceuticals
RAJEEV BUDHDEV | Executive Vice President & Head – API R&D | Dr. Reddy’s Laboratories
RUTH HARDY | Director Chemical Research | Pfizer
MIKE GIBSON | Chief Technical Officer | Sterling Pharma Solutions